1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics in North America Countries, September 2016

Drug Discovery and Development Analysis & Statistics in North America Countries, September 2016

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States, Europe, North America
Trends in Gene Therapy

Trends in Gene Therapy

  • $ 5 000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : Europe, United States
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • August 2016
  • by Global Data

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Cancer, Pathology, Drug Discovery and Development
  • Countries : United States
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • August 2016
  • by Global Data

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Cancer, Pathology, Drug Discovery and Development
  • Countries : United States
Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016

Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • August 2016
  • by Global Data

Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016" provides ...

  • Industries : Pathology, Pharmaceutical, Healthcare, Drug Discovery and Development, In Vitro Diagnostics
  • Countries : United States
Bone Fixation Plates - Medical Devices Pipeline Assessment, 2016

Bone Fixation Plates - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • August 2016
  • by Global Data

Bone Fixation Plates - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Bone Fixation Plates - Medical Devices Pipeline Assessment, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Paint and Coating, Manufacturing, Pharmaceutical, Orthopedics, Medical Device
  • Countries : United States
Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • July 2016
  • by Global Data

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Industrial Equipment, Machine Tool and Equipment, Drug Delivery
  • Countries : United States
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • July 2016
  • by Global Data

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Drug Discovery and Development
  • Countries : United States
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N Sulphoglucosamine Sulphohydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, United States
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 ...

  • Industries : Pathology, Cancer, Biopharmaceutical, Therapy
  • Countries : United States
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
Matrix Protein 1 (M1 or M) - Pipeline Review, H2 2016

Matrix Protein 1 (M1 or M) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Matrix Protein 1 (M1 or M) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Matrix Protein 1 (M1 or M) - Pipeline Review, H2 2016’, provides in depth analysis on Matrix Protein 1 (M1 ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : United States
Amyloid Precursor Protein (APP) - Pipeline Review, H2 2016

Amyloid Precursor Protein (APP) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Amyloid Precursor Protein (APP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Amyloid Precursor Protein (APP) - Pipeline Review, H2 2016’, provides in depth analysis on Amyloid Precurso ...

  • Industries : Mental Health, Biopharmaceutical, Pathology, Drug Discovery and Development
  • Countries : United States
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A(4) Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H2 2016

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A(4) Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A(4) Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Leukotriene A 4 Hydrolase (LTA 4 Hydrolase ...

  • Industries : Pathology, Therapy, Pharmaceutical, Drug Discovery and Development
  • Countries : World, United States
Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2016

Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Biopharmaceutical, Pathology
  • Countries : United States, World
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepcidin (Liver Expressed Antimicrobial Peptide ...

  • Industries : Pathology
  • Countries : United States, World
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2016

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase ...

  • Industries : Pathology, Cancer, Pharmaceutical
  • Countries : United States
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tyrosine Protein Kinase JAK3 (Janus Kinase ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Caspase 3 (Apopain ...

  • Industries : Therapy, Pathology, Biopharmaceutical
  • Countries : United States, World
T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 ...

  • Industries : Biological Therapy, Drug Discovery and Development, Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : World, United States
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016’, provides in depth analysis on Toll ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2016

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa Laminin-Binding Protein) - Pipeline Review, H1 2016

Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa Laminin-Binding Protein) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa Laminin-Binding Protein) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Pol Polyprotein - Pipeline Review, H1 2016

Pol Polyprotein - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Pol Polyprotein - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pol Polyprotein - Pipeline Review, H1 2016’, provides in depth analysis on Pol Polyprotein targeted pipeline therapeutics. ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical
  • Countries : United States
78 kda Glucose-Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+)-Binding Protein Grp78 or GRP78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain-Binding Protein or BiP or HSPA5) - Pipeline Review, H1 2016

78 kda Glucose-Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+)-Binding Protein Grp78 or GRP78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain-Binding Protein or BiP or HSPA5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

78 kda Glucose-Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+)-Binding Protein Grp78 or GRP78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain-Binding Protein or BiP or HSPA5) - Pipeline ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Caspase 9 (Apoptotic Protease Mch-6 or Apoptotic Protease-Activating Factor 3 or ICE-Like Apoptotic Protease 6 or EC 3.4.22.62) - Pipeline Review, H1 2016

Caspase 9 (Apoptotic Protease Mch-6 or Apoptotic Protease-Activating Factor 3 or ICE-Like Apoptotic Protease 6 or EC 3.4.22.62) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Caspase 9 (Apoptotic Protease Mch-6 or Apoptotic Protease-Activating Factor 3 or ICE-Like Apoptotic Protease 6 or EC 3.4.22.62) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Caspase ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016

70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, ...

  • Industries : Cancer, Biopharmaceutical, Drug Discovery and Development, Therapy, Pharmaceutical, Pathology
  • Countries : United States, World, United Kingdom
Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016

Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Aurora Kinase A (Serine ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States, China, World
Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Serine/Threonine-Protein Kinase Chk1 ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : World, United States
Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016’, provides in depth analysis on Toll ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.